inmunebio-041719.jpg Shares of INmune Bio Inc. (INMB) touched an all-time high of $11 on Tuesday (Apr.16), and that represents a gain of nearly 38% since their market debut in February.
phillyfed-index-041819.jpg A report released by the Federal Reserve Bank of Philadelphia on Thursday showed the pace of growth in regional manufacturing activity slowed by more than anticipated in the month of April following a significant rebound in the previous month.
bubbleboy-april18.jpg Shares of Mustang Bio Inc. (MBIO) soared more than 349 percent to $11.96 in extended trading on Wednesday, following encouraging results of the company's MB-107, an investigational lentiviral gene therapy for the treatment of bubble boy disease.
Follow RTT